PDBsum entry 3lcd

Transferase

PDB id: 3lcd

Contents

Protein chain

290 a.a.

Ligands

SO4 ×2

BDY

Waters ×44

References listed in PDB file

Key reference

• Title: Structure-Based drug design enables conversion of a dfg-In binding csf-1r kinase inhibitor to a dfg-Out binding mode.
• Authors: M.J.Meyers, M.Pelc, S.Kamtekar, J.Day, G.I.Poda, M.K.Hall, M.L.Michener, B.A.Reitz, K.J.Mathis, B.S.Pierce, M.D.Parikh, D.A.Mischke, S.A.Long, J.J.Parlow, D.R.Anderson, A.Thorarensen.
• Ref.: Bioorg Med Chem Lett, 2010, 20, 1543-1547.
• PubMed id: 20137931

Abstract

The work described herein demonstrates the utility of structure-based drug design (SBDD) in shifting the binding mode of an HTS hit from a DFG-in to a DFG-out binding mode resulting in a class of novel potent CSF-1R kinase inhibitors suitable for lead development.